Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Nektar Therapeutics

subscribe
Highlights

A collection of news and information related to Nektar Therapeutics published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-1 of 1
» View wsbt.com items only
    Jul 22, 2010 |Story| South Florida Sun-Sentinel

  1. Nektar Drug Helps Ovarian Cancer Patients

    About 48 percent of women with advanced ovarian cancer saw sustained benefits from treatment with Nektar Therapeutics' experimental drug NKTR-102 in a mid-stage study, the company said.
    Reuters
    About 48 percent of women with advanced ovarian cancer saw sustained benefits from treatment with Nektar Therapeutics' experimental drug NKTR-102 in a mid-stage study, the company said. Twenty-three percent of patients on a dose schedule of once every...

    Tags: Gynecology, Oncology, Obstetrics, Cancer, Diseases and Illnesses